Olorofim

olorofim · F2G Biotech GmbH

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Olorofim, covering 2024-07-10 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Olorofim in Early Coccidioidal Meningitis [Phase 2]